| Product Code: ETC13272975 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endovascular Stent Grafts Market was valued at USD 4.1 Billion in 2024 and is expected to reach USD 7.3 Billion by 2031, growing at a compound annual growth rate of 8.00% during the forecast period (2025-2031).
The Global Endovascular Stent Grafts Market is experiencing steady growth driven by an increasing prevalence of cardiovascular diseases, technological advancements in stent graft design, and rising demand for minimally invasive procedures. Stent grafts are commonly used in the treatment of abdominal and thoracic aortic aneurysms, providing a less invasive alternative to traditional surgery. Key market players are focusing on product innovation, clinical research, and strategic collaborations to enhance their market presence. North America currently dominates the market, attributed to a high prevalence of aortic aneurysms and well-established healthcare infrastructure. However, the Asia-Pacific region is expected to exhibit significant growth opportunities due to improving healthcare facilities and a growing geriatric population. Overall, the Global Endovascular Stent Grafts Market is projected to continue its upward trajectory in the coming years.
The Global Endovascular Stent Grafts Market is witnessing a surge in demand due to the increasing prevalence of cardiovascular diseases and a growing aging population. Technological advancements in stent graft design, such as improved materials and customization options, are driving market growth. Additionally, the rise in minimally invasive procedures and the preference for endovascular treatments over traditional open surgeries are boosting the adoption of endovascular stent grafts. Opportunities in the market include the development of bioresorbable stent grafts, expansion into emerging markets with unmet medical needs, and strategic collaborations between manufacturers and healthcare providers to enhance product accessibility. Overall, the Global Endovascular Stent Grafts Market is poised for continued growth and innovation in the coming years.
The Global Endovascular Stent Grafts Market faces several challenges including stringent regulatory approvals, reimbursement issues, and competition from alternative treatment options. The complex and evolving regulatory landscape can delay product launches and increase costs for manufacturers. Reimbursement challenges also impact market growth as the high cost of endovascular stent graft procedures may limit patient access. Additionally, the market faces competition from traditional surgical procedures and emerging technologies such as drug-eluting stents. Manufacturers in the endovascular stent graft market must navigate these challenges by investing in research and development to improve product efficacy, demonstrating cost-effectiveness to ensure reimbursement, and staying abreast of regulatory changes to maintain compliance and market competitiveness.
The global endovascular stent grafts market is primarily driven by the increasing prevalence of cardiovascular diseases and aortic aneurysms worldwide. The growing geriatric population, unhealthy lifestyle habits, and rising healthcare expenditure contribute to the high demand for minimally invasive procedures such as endovascular stent graft placement. Technological advancements in stent graft design, materials, and delivery systems also fuel market growth by improving the efficacy and safety of these devices. Additionally, the expanding awareness about the benefits of endovascular procedures over traditional open surgeries, such as reduced recovery time, shorter hospital stays, and lower risk of complications, further propels the market for endovascular stent grafts.
Government policies related to the Global Endovascular Stent Grafts Market primarily focus on regulatory approval processes, quality standards, and reimbursement policies. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU play a crucial role in assessing the safety and efficacy of stent grafts before they can be commercialized. These agencies enforce stringent requirements to ensure patient safety and product quality. Additionally, reimbursement policies set by government healthcare programs and private insurance companies influence market access and adoption rates of endovascular stent grafts. Manufacturers in the market must comply with these policies to navigate the regulatory landscape and secure reimbursement for their products, ultimately impacting market growth and competition.
The Global Endovascular Stent Grafts Market is projected to experience steady growth in the coming years due to the rising prevalence of cardiovascular diseases, technological advancements in stent graft designs, and increasing adoption of minimally invasive procedures. The market is expected to be driven by a growing aging population, higher demand for endovascular surgeries, and expanding awareness about the benefits of stent grafts in treating aortic aneurysms. Furthermore, the development of bioresorbable stent grafts and the emergence of new players in the market are likely to contribute to its continued expansion. However, challenges such as stringent regulatory requirements and high costs associated with endovascular procedures may hinder market growth to some extent. Overall, the Global Endovascular Stent Grafts Market is anticipated to exhibit promising opportunities for stakeholders in the healthcare industry.
In the Global Endovascular Stent Grafts Market, Asia is expected to witness significant growth driven by the rising prevalence of cardiovascular diseases and increasing healthcare expenditure in countries like China and India. North America is projected to dominate the market due to advanced healthcare infrastructure, high adoption of innovative medical technologies, and favorable reimbursement policies. Europe is also a key market with a growing aging population and increasing awareness about minimally invasive treatment options. The Middle East and Africa region is anticipated to experience steady growth attributed to improving healthcare facilities and rising awareness about endovascular procedures. Latin America is poised for growth due to the increasing prevalence of lifestyle-related diseases and investments in healthcare infrastructure.
Global Endovascular Stent Grafts Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endovascular Stent Grafts Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endovascular Stent Grafts Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endovascular Stent Grafts Market - Industry Life Cycle |
3.4 Global Endovascular Stent Grafts Market - Porter's Five Forces |
3.5 Global Endovascular Stent Grafts Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endovascular Stent Grafts Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Endovascular Stent Grafts Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Endovascular Stent Grafts Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endovascular Stent Grafts Market Trends |
6 Global Endovascular Stent Grafts Market, 2021 - 2031 |
6.1 Global Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endovascular Stent Grafts Market, Revenues & Volume, By nth t, 2021 - 2031 |
6.1.3 Global Endovascular Stent Grafts Market, Revenues & Volume, By l g l, 2021 - 2031 |
6.1.4 Global Endovascular Stent Grafts Market, Revenues & Volume, By nth t, 2021 - 2031 |
6.2 Global Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endovascular Stent Grafts Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.2.3 Global Endovascular Stent Grafts Market, Revenues & Volume, By Clinic, 2021 - 2031 |
6.2.4 Global Endovascular Stent Grafts Market, Revenues & Volume, By Medical Center, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Endovascular Stent Grafts Market, Overview & Analysis |
7.1 North America Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Endovascular Stent Grafts Market, Overview & Analysis |
8.1 Latin America (LATAM) Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Endovascular Stent Grafts Market, Overview & Analysis |
9.1 Asia Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Endovascular Stent Grafts Market, Overview & Analysis |
10.1 Africa Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Endovascular Stent Grafts Market, Overview & Analysis |
11.1 Europe Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Endovascular Stent Grafts Market, Overview & Analysis |
12.1 Middle East Endovascular Stent Grafts Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endovascular Stent Grafts Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endovascular Stent Grafts Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endovascular Stent Grafts Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Endovascular Stent Grafts Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Endovascular Stent Grafts Market Key Performance Indicators |
14 Global Endovascular Stent Grafts Market - Export/Import By Countries Assessment |
15 Global Endovascular Stent Grafts Market - Opportunity Assessment |
15.1 Global Endovascular Stent Grafts Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endovascular Stent Grafts Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Endovascular Stent Grafts Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Endovascular Stent Grafts Market - Competitive Landscape |
16.1 Global Endovascular Stent Grafts Market Revenue Share, By Companies, 2024 |
16.2 Global Endovascular Stent Grafts Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |